Wikidata

(Q63319636)

English

An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)

clinical trial

In more languages

Statements

short name
SMNRx (English)
0 references
title
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy (English)
0 references
medical condition
atrophy
0 references
muscular atrophy
0 references
start time
30 November 2011
0 references
end time
31 January 2013
0 references
number of participants
28
0 references
minimum age
2 year
0 references
maximum age
14 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63319636&oldid=1857125696"